Cancel

You have successfully logged out.

Oncology Solutions

Every infusion matters

B. Braun partners with pharmacy and oncology infusion centers to protect patients, protect staff and help optimize your infusion workflow — from pharmacy preparation through the final drop at the chair and into the home. One partner. Every touchpoint.

From pharmacy to infusion chair to home

U.S. healthcare workers potentially exposed to hazardous drugs.¹

0M

Exposure risk exists across the entire chemotherapy workflow, from compounding to administration.
U.S. ambulatory infusion market expected to nearly triple by 2035.²

0X

Oncology represents approximately one-third of the market.³
U.S. IV bags that still contain DEHP.
Up to

0%

Alternatives exist and should be considered to reduce potential negative patient impacts.⁴

Infographic showing a four-step infusion therapy workflow from acute care to home care, including order validation, pharmacy preparation, safe patient treatment and transition of care.

ORDERING

Safety and efficiency starts before the first drug is ordered

The foundation of safe, efficient infusion is a standardized drug library. B. Braun's DoseTrac® Enterprise Infusion Management Software enables infusion centers to build and manage oncology-specific drug libraries integrated directly with the EMR, ensuring that every regimen is programmed with guardrails in place before the patient sits down. DoseGuard® provides real-time dose error reduction at the point of programming. Together with the Space® Drug Library, they close the gap between what the order says and what the pump delivers — reducing alert burden, eliminating manual transcription and standardizing care across every infusion chair.

Oncology Website Page Image - safety-you-can-count-on-image

Nurse with a mask and dressed in protective clothing looking at patient while holding OnGuard 2 CSTD.

PHARMACY PREPARATION

Protection during preparation

B. Braun’s OnGuard® 2 Closed System Transfer Device (CSTD) helps protect pharmacy staff from hazardous drug exposure while reducing preparation variability, potential waste and the risk of error. Beyond hazardous drug handling, B. Braun’s PINNACLE® and APEX® Compounding Systems help automate and standardize complex admixture preparation, minimizing manual steps and supporting greater accuracy in daily pharmacy operations. And because oncology care extends beyond treatment administration, our parenteral nutrition solutions help clinicians provide critical nutrition therapy, expanding the pharmacy’s role from ensuring medication safety to supporting whole-patient care.

PATIENT TREATMENT

Preventing patient harm across the full infusion pathway from the pump to the patient

B. Braun's portfolio supports safe, efficient care across the oncology treatment journey. Minimize infusion errors with our Infusomat® Space® Smart Pump technology. Protect patients and clinicians from hazardous drug exposure with our OnGuard® 2 CSTD. Focus on improving vascular and port access success with the VeinVewer® Visualization Device^* and our Surecan™ Safety II port access needle. And all this while reducing patient risk and exposure to toxic chemicals — and preventing drug absorption as required for some standard chemotherapies — with our full non-DEHP infusion pathway.^**

Oncology Website Page Image - oncology-room-with-pumps-sqaure

Woman carrying a B. Braun Easypump® Elastomeric Pump System during infusion therapy.

TRANSITION OF CARE

Standardized solutions — Ensuring safety continues beyond the four hospital walls

As oncology care increasingly moves closer to the patient, B. Braun helps support the transition from the hospital to ambulatory infusion centers and into the home with infusion solutions designed for continuity. Offerings such as Easypump® Elastomeric Pump System enable therapy delivery across care settings, helping promote patient mobility, enhance the treatment experience and support care that moves with the patient wherever they go.

Ready to improve safety, efficiency and patient experience across your infusion center?

Talk to a dedicated B. Braun oncology specialist. Our team is focused exclusively on Integrated Delivery Networks across the continuum of care with specialized outpatient oncology experts and is ready to help you build a safe, efficient infusion program that works for your patients and your staff.

First name *

Last name *

Title *

Facility name *

Email *

Phone

Please select your country code.

Phone number is too long. It must be maximum 15 digits, including the country code (e.g., +12025550123).

Phone number is too short. It must be at least 9 digits, including the country code (e.g., +12025550123).

Invalid number.

Primary Interest *

How can B. Braun help you?

Character limit exceeded: Characters: 0/32000

B. Braun may use your contact information to send you emails about our business products and service offerings. For more information see our Privacy Policy.

References

^*VeinViewer is a registered trademark of Christie Medical Holdings, Inc. Christie is the manufacturer and B. Braun is a distributor of VeinViewer.

**Non-DEHP = Not made with DEHP. There may be trace, non-intentional amounts of DEHP residue or by-product in the product (<1000 ppm or 0.1%bw).

**Non-PVC = Not made with PVC. There may be trace, non-intentional amounts of PVC residue or by-product in the product (<1000 ppm or 0.1%bw).

1. Centers for Disease Control and Prevention. “Hazardous Drugs Exposures in Healthcare.” National Institute for Occupational Safety and Health, March 3, 2026. Accessed Aug. 13, 2026. https://www.cdc.gov/niosh/healthcare/hazardous-drugs/

2. Precedence Research. “Ambulatory Infusion Centers Market Size, Share and Trends 2026 to 2035.” June 10, 2026. Accessed Aug. 13, 2026. Precedence Research.

3. Mordor Intelligence. “Ambulatory Infusion Centers Market Size & Share Analysis - Growth Trends and Forecast (2026-2031).” Accessed Aug. 13, 2026. Mordor Intelligence Ambulatory Infusion Centers Market Report.

4. Breast Cancer Prevention Partners. Toxic-Free IV: Getting Harmful Chemicals Out of IV Bags and Tubing. August 15, 2024. Accessed Aug. 13, 2026. Breast Cancer Prevention Partners.

Every infusion matters

On this page